Metformin Glibenclamide Capsules work by reducing hepatic glycogen production and stimulating insulin secretion from pancreatic beta cells, thereby lowering blood glucose levels. Metformin Glibenclamide Capsules is a compound preparation composed of Glibenclamide and Metformin Hydrochloride, Metformin Hydrochloride can reduce hepatic glycogen production, reduce glucose absorption and improve insulin sensitivity; Glibenclamide mainly stimulates pancreatic β-cells to secrete insulin. This product is suitable for patients with type 2 diabetes mellitus whose blood glucose level has not been satisfactorily controlled by dietary control and exercise therapy alone, and it can also be used as a secondary drug. There may be a risk of hypoglycemia when the body has insufficient calories or other hypoglycemic drugs are used at the same time, and blood glucose level and liver and kidney function should be monitored regularly during the use of the drug, and if there is any discomfort, go to the hospital promptly for medical consultation. Adverse reactions of this product also include diarrhea, nausea and vomiting, sometimes fatigue, headache rash, lactic acidosis, etc.; myocardial infarction, cardiogenic shock, congestive heart failure, patients with renal insufficiency and those who are allergic to this product are prohibited.